DK240190D0 - Middel og metode til acceleration af blodsammenklumpningslyse - Google Patents
Middel og metode til acceleration af blodsammenklumpningslyseInfo
- Publication number
- DK240190D0 DK240190D0 DK240190A DK240190A DK240190D0 DK 240190 D0 DK240190 D0 DK 240190D0 DK 240190 A DK240190 A DK 240190A DK 240190 A DK240190 A DK 240190A DK 240190 D0 DK240190 D0 DK 240190D0
- Authority
- DK
- Denmark
- Prior art keywords
- hapten
- acceleration
- binding molecule
- thrombolytic agent
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Surgical Instruments (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Error Detection And Correction (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17722288A | 1988-04-04 | 1988-04-04 | |
US17722288 | 1988-04-04 | ||
PCT/US1989/001065 WO1989009817A1 (en) | 1988-04-04 | 1989-03-15 | Composition and method for acceleration of clot lysis |
US8901065 | 1989-03-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK240190D0 true DK240190D0 (da) | 1990-10-04 |
DK240190A DK240190A (da) | 1990-10-04 |
DK174062B1 DK174062B1 (da) | 2002-05-13 |
Family
ID=22647707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199002401A DK174062B1 (da) | 1988-04-04 | 1990-10-04 | Kombineret præparat til anvendelse ved en fremgangsmåde til behandling af myocardieinfarkt |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0336693B1 (da) |
JP (1) | JP2871775B2 (da) |
KR (1) | KR100194113B1 (da) |
AT (1) | ATE114480T1 (da) |
AU (1) | AU628041B2 (da) |
CA (1) | CA1341377C (da) |
DE (1) | DE68919504T2 (da) |
DK (1) | DK174062B1 (da) |
ES (1) | ES2064435T3 (da) |
FI (1) | FI102812B (da) |
GR (1) | GR3015182T3 (da) |
HU (1) | HU207349B (da) |
NO (1) | NO301374B1 (da) |
WO (1) | WO1989009817A1 (da) |
ZA (1) | ZA892464B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5357042A (en) * | 1984-04-23 | 1994-10-18 | The General Hospital Corporation | Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity |
US5453269A (en) * | 1986-04-14 | 1995-09-26 | The General Hospital Corporation | Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use |
US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
US5609869A (en) * | 1988-08-19 | 1997-03-11 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5811265A (en) * | 1988-08-19 | 1998-09-22 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
JPH02268694A (ja) * | 1989-04-07 | 1990-11-02 | Teijin Ltd | 血栓溶解剤 |
AU734997B2 (en) * | 1996-09-20 | 2001-06-28 | General Hospital Corporation, The | Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
US6524675B1 (en) | 1999-05-13 | 2003-02-25 | 3M Innovative Properties Company | Adhesive-back articles |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0735340B2 (ja) * | 1985-05-23 | 1995-04-19 | 帝人株式会社 | 血栓溶解促進剤 |
KR880701107A (ko) * | 1986-05-15 | 1988-07-25 | 원본미기재 | 피브린용해 조성물 |
-
1989
- 1989-03-15 HU HU892304A patent/HU207349B/hu not_active IP Right Cessation
- 1989-03-15 JP JP1503381A patent/JP2871775B2/ja not_active Expired - Fee Related
- 1989-03-15 AU AU32845/89A patent/AU628041B2/en not_active Ceased
- 1989-03-15 KR KR1019890702259A patent/KR100194113B1/ko not_active IP Right Cessation
- 1989-03-15 WO PCT/US1989/001065 patent/WO1989009817A1/en active IP Right Grant
- 1989-03-29 CA CA000594988A patent/CA1341377C/en not_active Expired - Fee Related
- 1989-04-04 ES ES89303293T patent/ES2064435T3/es not_active Expired - Lifetime
- 1989-04-04 EP EP89303293A patent/EP0336693B1/en not_active Expired - Lifetime
- 1989-04-04 ZA ZA892464A patent/ZA892464B/xx unknown
- 1989-04-04 AT AT89303293T patent/ATE114480T1/de not_active IP Right Cessation
- 1989-04-04 DE DE68919504T patent/DE68919504T2/de not_active Expired - Fee Related
-
1990
- 1990-10-03 FI FI904867A patent/FI102812B/fi not_active IP Right Cessation
- 1990-10-03 NO NO904294A patent/NO301374B1/no not_active IP Right Cessation
- 1990-10-04 DK DK199002401A patent/DK174062B1/da not_active IP Right Cessation
-
1995
- 1995-02-27 GR GR940403885T patent/GR3015182T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0336693A2 (en) | 1989-10-11 |
HUT56394A (en) | 1991-08-28 |
JP2871775B2 (ja) | 1999-03-17 |
JPH03504717A (ja) | 1991-10-17 |
HU892304D0 (en) | 1991-07-29 |
ZA892464B (en) | 1989-12-27 |
AU628041B2 (en) | 1992-09-10 |
WO1989009817A1 (en) | 1989-10-19 |
FI102812B1 (fi) | 1999-02-26 |
DE68919504T2 (de) | 1995-06-29 |
NO904294D0 (no) | 1990-10-03 |
EP0336693B1 (en) | 1994-11-30 |
EP0336693A3 (en) | 1990-03-21 |
FI904867A0 (fi) | 1990-10-03 |
KR100194113B1 (ko) | 1999-06-15 |
ATE114480T1 (de) | 1994-12-15 |
KR900700129A (ko) | 1990-08-11 |
HU207349B (en) | 1993-03-29 |
DK174062B1 (da) | 2002-05-13 |
FI102812B (fi) | 1999-02-26 |
ES2064435T3 (es) | 1995-02-01 |
CA1341377C (en) | 2002-07-16 |
DE68919504D1 (de) | 1995-01-12 |
NO301374B1 (no) | 1997-10-20 |
NO904294L (no) | 1990-12-04 |
AU3284589A (en) | 1989-11-03 |
GR3015182T3 (en) | 1995-05-31 |
DK240190A (da) | 1990-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO885109L (no) | Fremgangsmaate og middel for aa forhindre blodpropp. | |
BR9708859A (pt) | Composto uso do mesmo composição para inibir formação de trombo em sangue e processos para inibir trombina e formação de agregados de plaquetas sanguíneas e de trombo no sangue para tratar ou evitar tromboemolismo venoso e embolismo pulmonar trombose tromboembolismo cardiogênico acidente vascular cerebral trombose angina instável infartação miocárdica aterosclerose distúrbio cardaco isquêmico reoclus o restenose oclus o de enxertos de derivação de artéria coronária e doença cerebrovascular oclus | |
DK240190D0 (da) | Middel og metode til acceleration af blodsammenklumpningslyse | |
ATE250604T1 (de) | Pyridyl enthaltende spirocyclische verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation | |
DK0788546T3 (da) | Nematode-ekstraherede serinproteaseinhibitorer og antikoagulerende proteiner | |
PL350042A1 (en) | Serine protease inhibitors | |
ATE73332T1 (de) | Neuartige verwendung von taurolin. | |
IT8820882A0 (it) | Inibitori della endopeptidasi neutra. | |
FI922609A0 (fi) | Proteiner och nukleinsyror. | |
AU7371587A (en) | Peptides that inhibit binding of Von Willebrand factor binding | |
ES2076965T3 (es) | Activadores del plasminogeno salivares del murcielago vampiro. | |
AU1830392A (en) | A parenterally administrable drug having thrombolytic activity and containing protein c | |
DE68919311D1 (de) | Selbstinduzierte Reparatur von Leiterzügen. | |
DK226889A (da) | Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation | |
ATE84724T1 (de) | Gewisse paf-antagonist/antihistamin-mischungen und verfahren. | |
NO872875L (no) | Modifisert vevsplasminaktivator, samt fremgangsmte for fremstilling av en slik. | |
ATE440108T1 (de) | Plasmin-inhibitoren von der australischen braunen schlange, pseudonaja textilis textilis | |
Jang et al. | A randomized, blinded study of two doses of Novastan®(brand of argatroban) versus heparin as adjunctive therapy to recombinant tissue plasminogen activator (accelerated administration) in acute myocardial infarction: Rationale and design of the Myocardial Infarction using Novastan® and t-PA (MINT) study | |
Preissner et al. | Influence of fibrinogen on fibrin polymerization. Ultracentrifugation studies | |
ATE191278T1 (de) | Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen | |
FI932194A0 (fi) | Anvaendningen av protrombinfragment | |
DK0525252T3 (da) | Anvendelse af stafylokinase til fremstilling af en farmaceutisk sammensætning til behandling af arteriel thrombose. | |
Triantaphyllopoulos | Inactivation of Factor VIII by a Mechanism Independent of the Generation of Thrombin | |
Loeliger et al. | Further Data about the Clotting Insignificance of Coumarin Induced Prefactors | |
Cugno et al. | 289 Comparison of methods for t-PA and PAI activity used for evaluation of response to venous occlusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |